奎
DGX
奎斯特診斷
198.02
+0.33+0.17%After Hours: 198.02 0.00 0.00%17:42 04/02 EDT
OPEN/PREV CLOSE196.66/197.69
TODAY RANGE196.06-199.14
VOL519.96K
MARKET CAP21.76B
52 WEEK RANGE155.09-213.50
AVG VOL (3M)989.17K
% TURNOVER0.47%
TURNOVER--
P/E (TTM)22.65
% RANGE1.46%
EPS(TTM)8.74
P/E(FORWARD)20.89
P/B3.038
BVPS65.18
DIVIDEND3.440
P/S1.974
BETA--
DIV YIELD1.74%
FREE FLOAT MKT CAP21.65B
SHARES OUTSTANDING109.87M
NEXT EARNINGS04/20-04/24
FREE FLOAT109.35M
LOT SIZE1
EX-DATE04/06/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags
Simply Wall St·5d ago
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Swings
Seeking Alpha·03/27 22:37
Dividend Champion, Contender, And Challenger Highlights: Week Of March 29
Barchart·03/27 07:17
Quest Diagnostics Earnings Preview: What to Expect
Seeking Alpha·03/24 21:05
Moderna stands as the best performing large-cap healthcare stock YTD
Barchart·03/24 08:46
Is Henry Schein Stock Underperforming the S&P 500?
Barchart·03/23 07:59
Is Labcorp Holdings Stock Underperforming the S&P 500?
Simply Wall St·03/21 23:07
How Investors May Respond To Quest Diagnostics (DGX) Expanding Blood-Based Cancer Screening And Boardroom Expertise
PR Newswire·03/19 14:00
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
Barchart·03/19 05:38
How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks?
Barchart·03/18 05:28
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Simply Wall St·03/17 23:22
A Look At Quest Diagnostics (DGX) Valuation As Shares Trade Below Fair Value Estimate
NASDAQ·03/17 14:32
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.